Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)

NCT06956248 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

OTHER: Off-label or non-standard systemic therapies

Sponsor

National Cancer Centre, Singapore

Collaborators

SingHealth Duke-NUS Academic Medical Centre